MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, A.
Right arrow Articles by Hamilton, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, A.
Right arrow Articles by Hamilton, S. L.

Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel

A Chu, M Diaz-Munoz, MJ Hawkes, K Brush and SL Hamilton

Department of Medicine, Methodist Hospital, Houston, Texas.

In this paper, we study the modulation of the rabbit fast twitch skeletal muscle calcium release channel by assaying the kinetics of [3H]ryanodine binding, 45Ca2+ flux, and single-channel activity. The effects of modulators of the Ca2+ release channel (confirmed here with both flux and single-channel data) were examined for effects on [3H]ryanodine binding to terminal cisternae vesicles. We find that activators of the release channel, such as adenine nucleotides (1 mM) and caffeine (1 mM), enhance the rate of association of [3H]ryanodine, whereas inhibitors, such as Mg2+ (1 mM) and ruthenium red (100 nM), decrease the rate of association. High concentrations of either ryanodine or ruthenium red, which close the channel, slow the dissociation of [3H]ryanodine, suggesting that at these concentrations the inhibitory effects of both ryanodine and ruthenium red occur as the result of binding at a site distinct from but interacting cooperatively with the high affinity site. Our data are consistent with a model in which the high affinity ryanodine binding site is within a conformationally sensitive area of the channel, such that conditions that open the channel (ATP, caffeine, etc.) enhance the rate at which [3H]ryanodine reaches its binding site and other conditions that close the channel (the binding of ryanodine and ruthenium red to a low affinity site) slow the dissociation of [3H]ryanodine from the high affinity site. Some conditions that inhibit channel activity (high concentrations of Mg2+ and Ca2+) slow association but do not affect dissociation of bound [3H]ryanodine, suggesting a completely different state of the channel from that which is inactive in the presence of high concentrations of ryanodine or ruthenium red. In summary, the functional state of the fast twitch skeletal muscle calcium release channel can be characterized by the changes in the kinetics of [3H]ryanodine binding. Different modulators (activators/inhibitors) affect different aspects of ryanodine binding (association/dissociation).

Volume 37, Issue 5, pp. 735-741, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Aracena-Parks, S. A. Goonasekera, C. P. Gilman, R. T. Dirksen, C. Hidalgo, and S. L. Hamilton
Identification of Cysteines Involved in S-Nitrosylation, S-Glutathionylation, and Oxidation to Disulfides in Ryanodine Receptor Type 1
J. Biol. Chem., December 29, 2006; 281(52): 40354 - 40368.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams
The Interaction of an Impermeant Cation with the Sheep Cardiac RyR Channel Alters Ryanoid Association
Mol. Pharmacol., June 1, 2006; 69(6): 1990 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Vornanen
Temperature and Ca2+ dependence of [3H]ryanodine binding in the burbot (Lota lota L.) heart
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R345 - R351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Balog, L. E. Norton, D. D. Thomas, and B. R. Fruen
Role of calmodulin methionine residues in mediating productive association with cardiac ryanodine receptors
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H794 - H799.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
L. Xiong, J.-Z. Zhang, R. He, and S. L. Hamilton
A Ca2+-Binding Domain in RyR1 that Interacts with the Calmodulin Binding Site and Modulates Channel Activity
Biophys. J., January 1, 2006; 90(1): 173 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. I. DeHaven and J. Cuevas
VPAC Receptor Modulation of Neuroexcitability in Intracardiac Neurons: DEPENDENCE ON INTRACELLULAR CALCIUM MOBILIZATION AND SYNERGISTIC ENHANCEMENT BY PAC1 RECEPTOR ACTIVATION
J. Biol. Chem., September 24, 2004; 279(39): 40609 - 40621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, J. Bolstad, H. Kong, L. Zhang, C. Brown, and S. R. W. Chen
The Predicted TM10 Transmembrane Sequence of the Cardiac Ca2+ Release Channel (Ryanodine Receptor) Is Crucial for Channel Activation and Gating
J. Biol. Chem., January 30, 2004; 279(5): 3635 - 3642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen
Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction
J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. Vazquez-Martinez, R. Canedo-Merino, M. Diaz-Munoz, and J. R. Riesgo-Escovar
Biochemical characterization, distribution and phylogenetic analysis of Drosophila melanogaster ryanodine and IP3 receptors, and thapsigargin-sensitive Ca2+ ATPase
J. Cell Sci., June 15, 2003; 116(12): 2483 - 2494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-W. Xiong, R. A. Newman, G. G. Rodney, O. Thomas, J.-Z. Zhang, A. Persechini, M. A. Shea, and S. L. Hamilton
Lobe-dependent Regulation of Ryanodine Receptor Type 1 by Calmodulin
J. Biol. Chem., October 18, 2002; 277(43): 40862 - 40870.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Fill and J. A. Copello
Ryanodine Receptor Calcium Release Channels
Physiol Rev, October 1, 2002; 82(4): 893 - 922.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. R. Bidasee, U. D. Dincer, and H. R. Besch Jr.
Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats
Mol. Pharmacol., December 1, 2001; 60(6): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS, October 31, 2001; (2001) 241516898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen
Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation
J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 8, 2001; (2001) 41608898.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. R. Fruen, J. M. Bardy, T. M. Byrem, G. M. Strasburg, and C. F. Louis
Differential Ca2+ sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin
Am J Physiol Cell Physiol, September 1, 2000; 279(3): C724 - C733.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. R. Bidasee, A. Maxwell, W. F. Reynolds, V. Patel, and H. R. Besch Jr.
Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1074 - 1083.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
J.-W. Liao, J.-J. Kang, S.-H. Liu, C.-R. Jeng, Y.-W. Cheng, C.-M. Hu, S.-F. Tsai, S.-C. Wang, and V. F. Pang
Effects of Cartap on Isolated Mouse Phrenic Nerve Diaphragm and Its Related Mechanism
Toxicol. Sci., June 1, 2000; 55(2): 453 - 459.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Sharma, L. H. Jeyakumar, S. Fleischer, and T. Wagenknecht
Three-dimensional Structure of Ryanodine Receptor Isoform Three in Two Conformational States as Visualized by Cryo-electron Microscopy
J. Biol. Chem., March 24, 2000; 275(13): 9485 - 9491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Xu, A. Tripathy, D. A. Pasek, and G. Meissner
Ruthenium Red Modifies the Cardiac and Skeletal Muscle Ca2+ Release Channels (Ryanodine Receptors) by Multiple Mechanisms
J. Biol. Chem., November 12, 1999; 274(46): 32680 - 32691.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. D. Buck, W. G. Lachnit, and I. N. Pessah
Mechanisms of delta -Hexachlorocyclohexane Toxicity: I. Relationship Between Altered Ventricular Myocyte Contractility and Ryanodine Receptor Function
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 477 - 485.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Liu, D. A. Pasek, and G. Meissner
Modulation of Ca2+-gated cardiac muscle Ca2+-release channel (ryanodine receptor) by mono- and divalent ions
Am J Physiol Cell Physiol, January 1, 1998; 274(1): C120 - C128.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Sudo and T. E. Nelson
Changes in Ryanodine-Induced Contractures by Stimulus Frequency in Malignant Hyperthermia Susceptible and Malignant Hyperthermia Nonsusceptible Dog Skeletal Muscle
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1331 - 1336.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. M. Empson and A. Galione
Cyclic ADP-ribose Enhances Coupling between Voltage-gated Ca2+ Entry and Intracellular Ca2+ Release
J. Biol. Chem., August 22, 1997; 272(34): 20967 - 20970.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. H. DiJulio, E. L. Watson, I. N. Pessah, K. L. Jacobson, S. M. Ott, E. D. Buck, and J. C. Singh
Ryanodine Receptor Type III (Ry3R) Identification In Mouse Parotid Acini. PROPERTIES AND MODULATION OF [3H]RYANODINE-BINDING SITES
J. Biol. Chem., June 20, 1997; 272(25): 15687 - 15696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Z. Zamudio, R. Conde, C. Arevalo, B. Becerril, B. M. Martin, H. H. Valdivia, and L. D. Possani
The Mechanism of Inhibition of Ryanodine Receptor Channels by Imperatoxin I, a Heterodimeric Protein from the Scorpion Pandinus imperator
J. Biol. Chem., May 2, 1997; 272(18): 11886 - 11894.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Richter, L. Schleithoff, T. Deufel, F. Lehmann-Horn, and A. Herrmann-Frank
Functional Characterization of a Distinct Ryanodine Receptor Mutation in Human Malignant Hyperthermia-susceptible Muscle
J. Biol. Chem., February 21, 1997; 272(8): 5256 - 5260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Aghdasi, J.-Z. Zhang, Y. Wu, M. B. Reid, and S. L. Hamilton
Multiple Classes of Sulfhydryls Modulate the Skeletal Muscle Ca2+ Release Channel
J. Biol. Chem., February 7, 1997; 272(6): 3739 - 3748.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Meissner, E. Rios, A. Tripathy, and D. A. Pasek
Regulation of Skeletal Muscle Ca2+ Release Channel (Ryanodine Receptor) by Ca2+ and Monovalent Cations and Anions
J. Biol. Chem., January 17, 1997; 272(3): 1628 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. El-Hayek, A. J. Lokuta, C. Arévalo, and H. H. Valdivia
Peptide Probe of Ryanodine Receptor Function
J. Biol. Chem., December 1, 1995; 270(48): 28696 - 28704.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. R. Nimer, D. H. Needleman, S. L. Hamilton, J. Krall, and M. A. Movsesian
Effect of Ryanodine on Sarcoplasmic Reticulum Ca2+ Accumulation in Nonfailing and Failing Human Myocardium
Circulation, November 1, 1995; 92(9): 2504 - 2510.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Parness and S. S. Palnitkar
Identification of Dantrolene Binding Sites in Porcine Skeletal Muscle Sarcoplasmic Reticulum
J. Biol. Chem., August 4, 1995; 270(31): 18465 - 18472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. El-Hayek, M. Yano, and N. Ikemoto
A Conformational Change in the Junctional Foot Protein Is Involved in the Regulation of Ca[IMAGE] Release from Sarcoplasmic Reticulum
J. Biol. Chem., June 30, 1995; 270(26): 15634 - 15638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Treves, G. Feriotto, L. Moccagatta, R. Gambari, and F. Zorzato
Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane
J. Biol. Chem., December 8, 2000; 275(50): 39555 - 39568.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 27, 2001; 98(5): 2865 - 2870.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS, November 20, 2001; 98(24): 13625 - 13630.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics